Sarah Joanne Aves

Person

Hertfordshire, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine...
- Patent number 11,680,053
- Issue date Jun 20, 2023
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine...
- Patent number 11,584,732
- Issue date Feb 21, 2023
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
- Patent number 10,981,889
- Issue date Apr 20, 2021
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
- Patent number 10,584,111
- Issue date Mar 10, 2020
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Orexin receptor antagonists
- Patent number 10,316,028
- Issue date Jun 11, 2019
- Heptares Therapeutics Limited
- Miles Stuart Congreve
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
- Patent number 10,246,432
- Issue date Apr 2, 2019
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Orexin receptor antagonists
- Patent number 9,850,237
- Issue date Dec 26, 2017
- Heptares Therapeutics Limited
- Miles Stuart Congreve
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
- Patent number 9,676,745
- Issue date Jun 13, 2017
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Orexin receptor antagonists
- Patent number 9,555,044
- Issue date Jan 31, 2017
- Heptares Therapeutics Limited
- Miles Stuart Congreve
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Orexin receptor antagonists
- Patent number 9,249,160
- Issue date Feb 2, 2016
- Heptares Therapeutics Limited
- Miles Stuart Congreve
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
- Publication number 20240092754
- Publication date Mar 21, 2024
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
- Publication number 20220056009
- Publication date Feb 24, 2022
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
- Publication number 20210309632
- Publication date Oct 7, 2021
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
- Publication number 20200172505
- Publication date Jun 4, 2020
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
- Publication number 20190177297
- Publication date Jun 13, 2019
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OREXIN RECEPTOR ANTAGONISTS
- Publication number 20180370961
- Publication date Dec 27, 2018
- Heptares Therapeutics Limited
- Miles Stuart Congreve
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
- Publication number 20170275265
- Publication date Sep 28, 2017
- Heptares Therapeutics Limited
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OREXIN RECEPTOR ANTAGONISTS
- Publication number 20170121320
- Publication date May 4, 2017
- Heptares Therapeutics Limited
- Miles Stuart Congreve
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OREXIN RECEPTOR ANTAGONISTS
- Publication number 20160213678
- Publication date Jul 28, 2016
- Heptares Therapeutics Limited
- Miles Stuart Congreve
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
- Publication number 20160145236
- Publication date May 26, 2016
- HEPTARES THERAPEUTICS LIMITED
- John Andrew Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OREXIN RECEPTOR ANTAGONISTS
- Publication number 20150126498
- Publication date May 7, 2015
- Miles Stuart Congreve
- C07 - ORGANIC CHEMISTRY

Sarah Joanne Aves

Person

Patents Grantslast 30 patents

Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine...

Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine...

4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators

4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators

Orexin receptor antagonists

4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators

Orexin receptor antagonists

4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators

Orexin receptor antagonists

Orexin receptor antagonists

Patents Applicationslast 30 patents

4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

OREXIN RECEPTOR ANTAGONISTS

4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

OREXIN RECEPTOR ANTAGONISTS

OREXIN RECEPTOR ANTAGONISTS

4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

OREXIN RECEPTOR ANTAGONISTS